Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
fulyu baoxin keli
- Development stage
- Unknown
- Lead developer
- Tonghua Wantong Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Fulyu Baoxin Keli is a Traditional Chinese Medicine (TCM) granule developed by Tonghua Wantong Pharmaceutical for the treatment of cardiovascular conditions. It is primarily indicated for premature ventricular contractions (PVC) and coronary heart disease (CHD), particularly in patients presenting with Qi and Yin deficiency and blood stasis according to TCM diagnostic criteria. The formulation is composed of several herbal ingredients, including Ginseng (人参), Ophiopogon japonicus (麦冬), Schisandra chinensis (五味子), Salvia miltiorrhiza (丹参), Nardostachys jatamansi (甘松), and Sophora flavescens (苦参). Pharmacologically, it exerts anti-arrhythmic effects by modulating cardiac ion channels, specifically inhibiting sodium, potassium, and calcium currents, which helps stabilize the heart rhythm. Additionally, it improves myocardial blood supply and provides antioxidant protection to the heart tissue. It is widely utilized in clinical practice in China to alleviate symptoms such as palpitations, chest pain, and shortness of breath.
- Brand names
- Fulyu BaoxinpingFulyu Baoxin Keli
- Other names
- Fulyu Baoxin GranulesFulyu Baoxin CapsuleFulyu Baoxin
02
Targets
KCNQ1 (Potassium voltage-gated channel subfamily KQT member 1)CaV (Voltage-gated calcium channel protein complex)NaV (Voltage-gated sodium channels)
Beyond the preview
Go deeper on fulyu baoxin keli.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on fulyu baoxin keli.